Protagonist Therapeutics, Inc. earnings per share and revenue
Estimated earnings per share for the next quarter are -0.59 USD, and revenue is expected to reach 56.67 M USD. Also watch annual changes over time to get a bigger picture of PTGX earnings per share and revenue dynamics.